Alterations in nasal microbiota of patients with amyotrophic lateral sclerosis by Kaixiong Liu, Qifu Guo, Ying Ding, Li Luo, Jianchai Huang, Qijie Zhang, Ting Gao, Xiuyuan Hao

“…Links between alterations in gut microbiota composition and amyotrophic lateral sclerosis (ALS) have previously been reported. …”
Get full text

Pain in amyotrophic lateral sclerosis: a narrative review by Soyoung Kwak

Subjects: “…amyotrophic lateral sclerosis…”
Get full text

Advances in sequencing technologies for amyotrophic lateral sclerosis research by Evan Udine, Angita Jain, Marka van Blitterswijk

Subjects: “…Amyotrophic lateral sclerosis…”
Get full text

MOLECULAR STRUCTURE OF AMYOTROPHIC LATERAL SCLEROSIS IN RUSSIAN POPULATION by N. Yu. Abramycheva, E. V. Lysogorskaya, Yu. S. Shpilyukova, A. S. Vetchinova, M. N. Zakharova, S. N. Illarioshkin

Get full text

Sonographic Phrenic Nerve Changes in Amyotrophic Lateral Sclerosis by Ovidijus Laucius, Justinas Drūteika, Renata Balnytė, Kęstutis Petrikonis, Miglė Ališauskienė, Antanas Vaitkus

“…Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects both the upper and lower motor neurons in the nervous system, causing muscle weakness and severe disability. …”
Get full text

Molecular imaging of microglial activation in amyotrophic lateral sclerosis. by Philippe Corcia, Clovis Tauber, Johnnie Vercoullie, Nicolas Arlicot, Caroline Prunier, Julien Praline, Guillaume Nicolas, Yann Venel, Caroline Hommet, Jean-Louis Baulieu, Jean-Philippe Cottier, Catherine Roussel, Mickael Kassiou, Denis Guilloteau, Maria-Joao Ribeiro

“…There is growing evidence of activated microglia and inflammatory processes in the cerebral cortex in amyotrophic lateral sclerosis (ALS). Activated microglia is characterized by increased expression of the 18 kDa translocator protein (TSPO) in the brain and may be a useful biomarker of inflammation. …”
Get full text

Progress in gene therapy mechanism of amyotrophic lateral sclerosis by LI Xiaoguang, YANG Lu, LIU Xudong, JIA Xinmiao, YANG Xinzhuang, CUI Liying

Subjects: “…amyotrophic lateral sclerosis|gene therapy|antisense oligonucleotides|rna interference|crispr-cas9…”
Get full text

Resilience, anxiety, and depression in amyotrophic lateral sclerosis patients by Alessia Demuru, Claudio Longobardi, Laura Elvira Prino, Michele Settanni

Subjects: “…amyotrophic lateral sclerosis…”
Get full text

Rate of speech decline in individuals with amyotrophic lateral sclerosis by Marziye Eshghi, Yana Yunusova, Kathryn P. Connaghan, Bridget J. Perry, Marc F. Maffei, James D. Berry, Lorne Zinman, Sanjay Kalra, Lawrence Korngut, Angela Genge, Annie Dionne, Jordan R. Green

“…Abstract Although speech declines rapidly in some individuals with amyotrophic lateral sclerosis (ALS), longitudinal changes in speech have rarely been characterized. …”
Get full text

An exploratory study on counterfactual thinking in amyotrophic lateral sclerosis by Barbara Poletti, Barbara Poletti, Edoardo Nicolò Aiello, Sofia Tagini, Federica Solca, Silvia Torre, Eleonora Colombo, Alessio Maranzano, Ruggero Bonetti, Francesco Schevegher, Claudia Morelli, Alberto Doretti, Federico Verde, Federico Verde, Sergio Barbieri, Francesca Mameli, Alberto Priori, Alberto Priori, Roberta Ferrucci, Roberta Ferrucci, Vincenzo Silani, Vincenzo Silani, Paolo Cherubini, Paolo Cherubini, Gabriella Pravettoni, Gabriella Pravettoni, Nicola Ticozzi, Nicola Ticozzi

Subjects: Get full text

Electrodiagnostic profile of conduction slowing in amyotrophic lateral sclerosis by Nizar Souayah, Ankit Pahwa, Mustafa Jaffry, Tejas Patel, Abu Nasar, Zhao Zhong Chong, Howard W. Sander

Subjects: “…Amyotrophic lateral sclerosis…”
Get full text

The role of TDP-43 protein in amyotrophic lateral sclerosis by Piotr Włodarczyk, Mikołaj Witczak, Agnieszka Gajewska, Tomasz Chady, Igor Piotrowski

Subjects: “…Amyotrophic lateral sclerosis…”
Get full text

Iranian clinical practice guideline for amyotrophic lateral sclerosis by Reza Boostani, Nahid Olfati, Hosein Shamshiri, Hosein Shamshiri, Zanireh Salimi, Zanireh Salimi, Farzad Fatehi, Farzad Fatehi, Seyed Arya Hedjazi, Atefeh Fakharian, Atefeh Fakharian, Atefeh Fakharian, Majid Ghasemi, Ali Asghar Okhovat, Ali Asghar Okhovat, Keivan Basiri, Keivan Basiri, Bahram Haghi Ashtiani, Behnaz Ansari, Behnaz Ansari, Behnaz Ansari, Gholam Reza Raissi, Gholam Reza Raissi, Seyed Ahmadreza Khatoonabadi, Payam Sarraf, Payam Sarraf, Sara Movahed, Sara Movahed, Akram Panahi, Akram Panahi, Bentolhoda Ziaadini, Bentolhoda Ziaadini, Mohammad Yazdchi, Mohammad Yazdchi, Jalal Bakhtiyari, Shahriar Nafissi, Shahriar Nafissi

Subjects: “…amyotrophic lateral sclerosis…”
Get full text

Palliative health care for amyotrophic lateral sclerosis patients by M. N. Zakharova, I. A. Avdunina, E. V. Lysogorskaia, A. A. Vorobyeva, M. V. Ivanova, A. V. Chervyakov, A. V. Vasiliev

Get full text

Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis by Júlia Costa, Marta Gromicho, Ana Pronto-Laborinho, Conceição Almeida, Ricardo A. Gomes, Ana C. L. Guerreiro, Abel Oliva, Susana Pinto, Mamede de Carvalho

Subjects: “…amyotrophic lateral sclerosis…”
Get full text

The Spectrum of Cognitive Dysfunction in Amyotrophic Lateral Sclerosis: An Update by Kurt A. Jellinger

“…Cognitive dysfunction is an important non-motor symptom in amyotrophic lateral sclerosis (ALS) that has a negative impact on survival and caregiver burden. …”
Get full text

Development of novel diagnostics and therapeutics for amyotrophic lateral sclerosis by Townsend, Seth A. (Seth Alan)

Get full text

Amyotrophic lateral sclerosis: cell vulnerability or system vulnerability? by Talbot, K

“…Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disease with clinical, pathological and genetic overlap with frontotemporal dementia (FTD). …”

Amyotrophic lateral sclerosis: Cell vulnerability or system vulnerability? by Talbot, K

“…Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disease with clinical, pathological and genetic overlap with frontotemporal dementia (FTD). …”

Lockhart Clarke's contribution to the description of amyotrophic lateral sclerosis. by Turner, M, Swash, M, Ebers, G

“…The definition of the clinicopathological entity of amyotrophic lateral sclerosis evolved over half a century. Although the definitive term amyotrophic lateral sclerosis that acknowledged both upper and lower motor neuron involvement was attributed to Jean-Martin Charcot in 1874, his initial case was published nearly a decade earlier; and it is accepted that, from at least the 1830s, several others (including Charles Bell, François-Amilcar Aran and Jean Cruveilhier) had already recognized a progressive lower motor neuron-only syndrome within a broader, clinically-defined group of disorders, termed progressive muscular atrophy. …”